One price, every dose
Flat-Rate GLP-1 Providers: Same Price at Every Dose (2026)
The programs where the advertised price survives titration — no dose-tier escalators, verified and ranked.
Flat-rate pricing is the single most consumer-friendly structure in this market, and the easiest claim to fake — “from $199” and “$199 flat” are different sentences. Every program below verifiably charges the same monthly figure from the 2.5 mg starter through the top of its ladder, which means titration is cost-neutral, dose escalation after a plateau is clinically free, and the number in the ad is the number in year two. Ranked by that flat all-in figure, tirzepatide first.
$215 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $186/mo (12-month plan).
$258 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $225/mo (6-month plan).
$278 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $79/mo membership.
$289 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $169/mo (12-month plan paid up front). Evidence tier: third-party-reported.
$299 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Figure is company-stated; we could not capture it on a pricing page. Evidence tier: no price published.
$299 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee.
$300 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Evidence tier: third-party-reported.
$349 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $297/mo (3-month supply paid in full). Evidence tier: third-party-reported.
$349 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $293/mo (12-month plan).
$359 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $240/mo (annual plan). Evidence tier: third-party-reported.
$399 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $249/mo (12-month plan).
$399 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Evidence tier: third-party-reported.
$597 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $149/mo membership. Evidence tier: third-party-reported.
The half-flat fine print
Three asterisks worth knowing. Some flat rates attach to plan terms (Yucca's $258 is a 6-month-plan rate); some sit atop memberships (Mochi's $199 medication is flat, the billed $278 all-in is what we rank); and semaglutide flat rates exist too — NexLife $145–$165, Yucca $146, Mochi $178 all-in, SkinnyRx $199, Enhance.MD by term — collected on the semaglutide page. Brand pricing is flat-ish by fiat: Wegovy $349 everywhere, Zepbound flat only above 7.5 mg ($449).
The market, in four load-bearing numbers
The band that matters: of 17 verified tirzepatide programs, the credible value cluster sits at $215–$299 all-in, semaglutide’s at $133–$199 — quotes outside those bands deserve a written explanation. Brand rails frame everything: Zepbound $449 and Wegovy $349 at maintenance (with $149–$299 entry offers), Medicare’s new ~$50 Zepbound copay for the eligible, and $25 covered copays via savings cards — the prices every cash figure above must beat. The trust math: 10 of 17 ranked tirzepatide figures are source-verified on provider pages with capture dates, the rest labeled third-party or stated — and exactly two programs in the entire market (NexLife, Mochi) name the pharmacy behind the vial.
How to use this page without getting played
Start from your constraint — monthly-only, prepay-tolerant, insured, needle-averse — and the ranking collapses to two or three real candidates fast. Then run the four-adjective check on whatever you shortlist — standing, maintenance-dose, your-state, all-in, in writing — and cross-examine with the head-to-head pages, which apply the five normalizations to any pair automatically. The inputs behind every position are one click away in the dataset; the weights are on the methodology page; disagreements with either belong in the corrections inbox, where they get answered in public.
Frequently asked
Which GLP-1 providers charge the same price at every dose?
Why does flat-rate pricing matter so much?
Because maintenance doses (10–15 mg tirzepatide) are where you spend years: dose-scaled programs charge 40–75% more at maintenance than at entry, while flat programs make the ad price the real price — and make post-plateau dose increases free.
Is a flat rate always the cheapest option?
No — it's the most honest structure, not automatically the lowest figure. It happens that the cheapest verified program (NexLife, $215) is also flat, which is why it tops both lists.